Skip to content

A clinical trial involving 10,025 children aged 2 to 14 showed a "very low" 56% efficacy rate for the Dengvaxia vaccine.

Machine-translated from Tagalog. Original: Ang clinical trial na kinasasangkutan ng 10,025 bata na may edad 2 hanggang 14 na taong gulang, ay nagpahiwatig ng "napakababang" 56% na efficacy rate para sa Dengvaxia vaccine.

Is it true?

Misleadingaccording to Vera Files

Vera Files checked this claim on 4 August 2022.

  1. Vera Files4 August 2022 · English

    “Needs context”

    Read the fact-check
  2. Vera Files4 August 2022 · Filipino

    “Nangangailangan ng konteksto”

    Read the fact-check

1 newsroom, 2 languages, 2022

Around this claim

Also known as
  • “The clinical trial which involved 10,025 children aged 2 to 14 years old, indicated a “very low” 56% efficacy rate for Dengvaxia vaccine.”

Also appears as

  • “The clinical trial which involved 10,025 children aged 2 to 14 years old, indicated a “very low” 56% efficacy rate for Dengvaxia vaccine.”

Related

Something wrong here? Report it by emailinfo@factiz.org

The verdict belongs to the newsroom: report an error in it to them, through their article above. Report an error in what Factiz added, such as the translation, the theme or the names, to us.

Record from: Data Commons (ClaimReview feed), with the fact-check of the newsroom named. Licence: CC BY 4.0. Factiz added the language, the verdict category and the grouping of the same claim.

The sources are the verdict.